Last reviewed · How we verify
A Randomized Trial to Compare the Efficacy of Artekin and Amodiaquine Plus Artesunate for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua
The primary aim of the comparative trial is to assess the relative safety and efficacy of two artemisinin containing regimens: amodiaquine plus artesunate (AAQ) and artekin both administered once daily for 3 days.
Details
| Lead sponsor | Menzies School of Health Research |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 400 |
| Start date | 2005-07 |
| Completion | 2005-12 |
Conditions
- Malaria, Falciparum
- Malaria, Vivax
Interventions
- Amodiaquine plus artesunate; Artekin
Primary outcomes
- Overall day 42 cure rate (incorporating early and late treatment failures)
Countries
Indonesia